Modeling sarcomagenesis using multipotent mesenchymal stem cells.
about
A semi-automated, KNIME-based workflow for biofilm assaysOsteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesEMT or EMT-Promoting Transcription Factors, Where to Focus the Light?Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potentialInhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcomaGenetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model.Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsEfficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9.Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells.Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma.The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either alleleStem cell bioprocess engineering towards cGMP production and clinical applicationsMyxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment.p53: the barrier to cancer stem cell formation.Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.Mesenchymal stem cell transformation and sarcoma genesis.Histologic and genetic advances in refining the diagnosis of "undifferentiated pleomorphic sarcoma"Liposarcoma in animals: literature review and case report in a domestic pig (Sus scrofa).Radiation-induced alterations of osteogenic and chondrogenic differentiation of human mesenchymal stem cells.Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.Passage-dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia.The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma.Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.Widespread Chromatin Accessibility at Repetitive Elements Links Stem Cells with Human Cancer.The paradigm of mutant p53-expressing cancer stem cells and drug resistance.Bone microenvironment signals in osteosarcoma development.Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.p53 and its mutants on the slippery road from stemness to carcinogenesis.ASPL-TFE3 Oncoprotein Regulates Cell Cycle Progression and Induces Cellular Senescence by Up-Regulating p21.Mesenchymal stem cells: From stem cells to sarcomas.Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells.Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation.Epigenetic and genetic changes in soft tissue sarcomas: a review.
P2860
Q24288891-4540AD5B-4BE4-4BBB-81D7-DE2419C564EBQ26745742-3F04211D-40D1-4E62-9BDE-6E9B40848775Q26995188-D351D30B-7D0E-4709-9341-764247014504Q27342050-C77C4184-9D19-48C3-98AE-45C4F7BB615EQ28484249-61919931-0E54-49B8-954E-47674AE175D7Q28597747-CE89EA41-0546-49B3-BC0C-E66EF2BD7D30Q33579181-018A84D1-8C18-46FF-802D-5657D2EA5B46Q33649056-AD36193C-1783-4CE2-A79A-B5FBBE357376Q33659569-4C992589-8C64-4DB1-9A6C-E0A06D6E234DQ33795203-7EE5C809-8BDF-4455-A4F1-B88FCB69230DQ33828556-852B4268-8FD2-4E68-8541-900AF0EA0274Q33889255-72618809-BAF7-4CC6-B305-3517093F4242Q33899910-38093DC1-1344-425B-B78D-88D599E2C2D5Q34038389-DFDAE440-8CF4-4E0C-9A07-FDDF6BA6DAAFQ34150828-DA94B020-5A84-45DE-81E3-710C0B1F2C04Q34263394-28EB5EA7-0E70-4365-B30A-DBACDEE394E8Q34402072-52CFDAAC-42CB-4518-8D57-15AEC566D8F8Q34406072-B3CCCB26-00F8-4BCD-90DE-0F0C3862AA5AQ34494731-5A06FA59-0B65-421F-AC7C-89A3183F95A2Q34654560-3873E85A-AB44-4857-927F-3C5B382F34F8Q34657369-5785F427-F5AF-444A-B612-83E51F6CFEFFQ34667636-B3C1161A-172C-4401-A3C8-6B012BA4866DQ35250371-DF069919-B3C4-4E42-AFCD-164A00ABC7B9Q36596264-10A6373E-E77D-42F0-801C-97C386A36ED8Q36945106-226848FF-FB6B-4BFD-B904-0BFA166186BBQ37043780-D3D88C4C-3121-4CDC-84F3-AD762DFCD0DCQ37464647-9D80C55B-BD54-4556-822A-84B903F036E7Q37544362-A363016B-B7EF-4300-BF60-075216C6C5A1Q37608149-FDB1517D-733D-4330-A11E-6ABF94A0A032Q38198487-B301FC00-646E-4E93-B931-9D529F360EE1Q38454980-E89987BF-02CD-46A3-B703-EF366C75F422Q38637192-2A58C1D5-7F25-4F69-B4EA-1BBE71399FDBQ38653083-82D1FBD2-582F-4CE2-89BC-1B5011E0E59CQ38740922-AE36A018-01A2-4328-BB7B-6E927628F11DQ38743525-690BD2FB-2F44-456C-B007-6761F306241BQ38780560-0DCD57AD-994D-4EEE-84BD-381C92A39C73Q38846785-2D77854D-3446-4E1D-AE8C-4D9D3026FF49Q38917207-20EB3993-9AEF-4B05-A7EB-F8FF04458E3CQ38943709-D4AB4313-A6EE-437E-B13E-FAAA54173826Q38964936-6259DE62-DDB3-4C4F-8F81-4BEA600CE88D
P2860
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
@en
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
@nl
type
label
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
@en
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
@nl
prefLabel
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
@en
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
@nl
P2860
P356
P1433
P1476
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
@en
P2093
Ruth Rubio
P2860
P2888
P356
10.1038/CR.2011.157
P577
2011-09-20T00:00:00Z